TGFBI and neoplasm: In subgroups divided by the expression levels of TGFBI, tumor immunosuppression‐related pathways, such as P53 signaling pathways, phosphoinositide 3‐kinase–protein kinase B (PI3K–AKT) signaling pathways, cell cycle pathways, tumor necrosis factor (TNF)‐κB signaling pathways, Janus kinase–signal transducer and activator of transcription signaling pathways, and apoptosis pathways, were enriched in high‐level expression groups.